Principal Investigator
Rani George, M.D., Ph.D.
Associate Professor of Pediatrics
Harvard Medical School
Dana 640
rani_george@dfci.harvard.edu
Associate Professor of Pediatrics
Harvard Medical School
Dana 640
rani_george@dfci.harvard.edu
Present Members
Bandana Sharma, Ph.D.
Lab Manager
Dana 640A
bandana_sharma@dfci.harvard.edu
Lab Manager
Dana 640A
bandana_sharma@dfci.harvard.edu
David Debruyne, Ph.D.
University of Nice Postdoctoral Fellow Recipient, Friends for Life Grant davidn_debruyne@dfci.harvard.edu |
"Leveraging in vitro cellular models of acquired resistance to ALK inhibition in high-risk neuroblastoma, my overall aim is to identify target candidates that could be translated into therapeutic strategies to prevent relapse in patients, as well as to gain a better understanding of tumor evolution under stress conditions in this deadly pediatric cancer."
|
Hao Huang, Ph.D.
Louisiana State University Postdoctoral Fellow Recipient, Grant Team Path to the Cure hao_huang@dfci.harvard.edu |
"My research project focuses on the molecular biology and biochemistry research of ALK, a Receptor Tyrosine Kinase closely related to neuroblastoma."
|
Malgorzata Krajewska , Ph.D.
University of Groningen, The Netherlands Postdoctoral Fellow Recipient, Rally Foundation for Childhood Cancer Research and Infinite Love for Kids Fighting Cancer malgorzata_krajewska@dfci.harvard.edu |
''My research is focused on understanding the molecular mechanisms underlying co-transcriptional RNA processing and their influence on genome stability''
|
Satyaki Sengupta, Ph.D.
Michigan State University Postdoctoral Fellow Recipient, Rally Foundation for Childhood Cancer Research satyaki_sengupta@dfci.harvard.edu |
"My research focus is to understand how MYCN contributes to oncogenic transcription in neuroblastoma."
|
Ruben Dries, Ph.D.
Erasmus MC, The Netherlands & KULeuven, Belgium Postdoctoral Fellow rdries@jimmy.harvard.edu |
"I use computational approaches to dissect high-dimensional datasets in order to study biological processes such as cellular plasticity during drug resistance and transcriptional processing. This provides a data-driven approach that, in collaboration with other people in the lab, allows us to gain significant insight in these complex biological problems."
|
Matthew Harlow, Ph.D.
Vanderbilt University Postdoctoral Fellow matthew_harlow@dfci.harvard.edu |
"I am interested in understanding the transcriptional processes that lead to tumor formation. In particular, I want to identify transcriptional dependencies that can be leveraged into improving patient outcomes."
|
Sanjukta Das, Ph.D.
Postdoctoral Fellow sanjukta_das@dfci.harvard.edu |
"I use integrative computational and statistical methods to analyze genomics and transcriptomics data in order to understand the underlying mechanism of transcription and molecular pathways in tumors."
|
Marina Volegova
University of California - Berkeley Postdoctoral Fellow marina_volegova@dfci.harvard.edu |
"My research focus is to investigate how cellular mRNA translation machinery and amplified MYCN in high risk neuroblastoma synergize at the level of translation regulation to drive unique gene expression programs to evade apoptosis and potentiate oncogenic activity."
|
Jim Lu
Undergraduate Student
Harvard University
jim_lu@dfci.harvard.edu
Undergraduate Student
Harvard University
jim_lu@dfci.harvard.edu
Monica Pomaville, BS
Medical Student Howard Hughes Medical Institute Medical Research Fellowship monicam_pomaville@dfci.harvard.edu |
"My research is focused on determining how activating mutations in ALK lead to altered transcription in neuroblastoma."
|
Chi Trinh
Undergraduate Student
Wellesley College
Undergraduate Student
Wellesley College
Alissa Joy
Administrative Assistant
Dana 640
(617) 582-8633
AlissaL_Joy@dfci.harvard.edu
Administrative Assistant
Dana 640
(617) 582-8633
AlissaL_Joy@dfci.harvard.edu
